Christopher Atkins

1.7k total citations
25 papers, 435 citations indexed

About

Christopher Atkins is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Christopher Atkins has authored 25 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 3 papers in Psychiatry and Mental health. Recurrent topics in Christopher Atkins's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Christopher Atkins is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Christopher Atkins collaborates with scholars based in United Kingdom, Australia and India. Christopher Atkins's co-authors include Andrew M. Wilson, Marek Ziebart, Yoon K. Loke, Jee Whang Kim, Anjali Crawshaw, Karen Patterson, Muhunthan Thillai, Nicholas Screaton, Vasileios Kouranos and Ling‐Pei Ho and has published in prestigious journals such as European Respiratory Journal, Thorax and BMJ Open.

In The Last Decade

Christopher Atkins

24 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Atkins United Kingdom 11 280 205 58 48 41 25 435
J. Pardo Spain 10 90 0.3× 58 0.3× 34 0.6× 39 0.8× 41 1.0× 39 375
Gianna Camiciottoli Italy 17 731 2.6× 229 1.1× 7 0.1× 10 0.2× 53 1.3× 33 857
Anna E. Sharrock United Kingdom 9 64 0.2× 17 0.1× 8 0.1× 35 0.7× 32 0.8× 9 291
Charles Ruehle United States 4 41 0.1× 65 0.3× 15 0.3× 24 0.5× 5 0.1× 6 334
Yuta Mori Japan 8 112 0.4× 79 0.4× 1 0.0× 11 0.2× 15 0.4× 47 338
Paul Tennant United States 10 136 0.5× 62 0.3× 29 0.5× 8 0.2× 10 0.2× 33 396
Tony Lin New Zealand 11 135 0.5× 27 0.1× 17 0.3× 12 0.3× 17 0.4× 39 476
Hajime Kasai Japan 12 277 1.0× 48 0.2× 48 1.0× 45 1.1× 80 512
Vičko Gluncić Croatia 10 134 0.5× 14 0.1× 4 0.1× 40 0.8× 70 1.7× 22 335
Biljana Zvezdin Serbia 9 223 0.8× 97 0.5× 4 0.1× 6 0.1× 19 0.5× 26 309

Countries citing papers authored by Christopher Atkins

Since Specialization
Citations

This map shows the geographic impact of Christopher Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Atkins more than expected).

Fields of papers citing papers by Christopher Atkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Atkins. The network helps show where Christopher Atkins may publish in the future.

Co-authorship network of co-authors of Christopher Atkins

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Atkins. A scholar is included among the top collaborators of Christopher Atkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Atkins. Christopher Atkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Atkins, Christopher, Andy Jones, Allan Clark, et al.. (2021). Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial. BMJ Open Respiratory Research. 8(1). e000814–e000814. 6 indexed citations
3.
Kim, Jee Whang, Allan Clark, Surinder S. Birring, et al.. (2021). Psychometric properties of patient reported outcome measures in idiopathic pulmonary fibrosis. Chronic Respiratory Disease. 18. 4053458245–4053458245. 16 indexed citations
4.
Thillai, Muhunthan, Abraham Samuel Babu, Helen Parfrey, et al.. (2020). Antifibrotic Persistence in Idiopathic Pulmonary Fibrosis: A Real-World Experience of 447 Patients. A3058–A3058. 1 indexed citations
5.
Thillai, Muhunthan, Christopher Atkins, Anjali Crawshaw, et al.. (2020). BTS Clinical Statement on pulmonary sarcoidosis. Thorax. 76(1). 4–20. 104 indexed citations
6.
Wilson, Nathan J., et al.. (2019). Educating the Future Nursing Workforce to Meet the Health Needs of People with Intellectual and Developmental Disability: Submission to the Independent Review of Nursing Education. 1 indexed citations
7.
Kim, Jee Whang, Christopher Atkins, & Andrew M. Wilson. (2018). Barriers to specialist palliative care in interstitial lung disease: a systematic review. BMJ Supportive & Palliative Care. 9(2). 130–138. 27 indexed citations
8.
Atkins, Christopher, Richard Fordham, Allan Clark, et al.. (2017). Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol. BMJ Open. 7(12). e018532–e018532. 6 indexed citations
9.
Yao, Henry H., et al.. (2017). Lower risk of pelvic metalware infection with operative repair of concurrent bladder rupture. ANZ Journal of Surgery. 88(6). 560–564. 9 indexed citations
10.
Atkins, Christopher, et al.. (2016). Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases.. PubMed. 33(2). 130–8. 19 indexed citations
11.
12.
Kotecha, Jalpa, Christopher Atkins, & Andrew M. Wilson. (2016). Patient confidence and quality of life in idiopathic pulmonary fibrosis and sarcoidosis.. PubMed. 33(4). 341–348. 10 indexed citations
13.
Atkins, Christopher & Marek Ziebart. (2015). Effectiveness of observation-domain sidereal filtering for GPS precise point positioning. GPS Solutions. 20(1). 111–122. 54 indexed citations
14.
Atkins, Christopher, et al.. (2015). Fatigue in sarcoidosis; effect on quality of life and health status. PA835–PA835. 1 indexed citations
15.
Atkins, Christopher, Tina Maheswaran, Simon Rushbrook, & Ajay Kamath. (2014). Lansoprazole-induced acute lung and liver injury: a case report. International Journal of Clinical Pharmacology and Therapeutics. 52(12). 1102–1104. 5 indexed citations
16.
Atkins, Christopher, Yoon K. Loke, & Andrew M. Wilson. (2013). Outcomes in idiopathic pulmonary fibrosis: A meta-analysis from placebo controlled trials. Respiratory Medicine. 108(2). 376–387. 67 indexed citations
17.
Roberts, Gethin Wyn, et al.. (2012). Deflection and frequency monitoring of the Forth Road Bridge, Scotland, by GPS. Proceedings of the Institution of Civil Engineers - Bridge Engineering. 165(2). 105–123. 26 indexed citations
18.
Atkins, Christopher, et al.. (2011). Pulmonary function in sarcoidosis: A review of 85 cases using percentage predicted and lower limit of normal values to determine pattern of pulmonary function deficit. European Respiratory Journal. 38(Suppl 55). p915–p915. 1 indexed citations
19.
Atkins, Christopher, et al.. (2010). Postural orthostatic tachycardia syndrome: a case report of palpitations and dizziness following prophylactic mefloquine use. International Journal of Clinical Pharmacology and Therapeutics. 48(9). 577–581. 3 indexed citations
20.
Atkins, Christopher. (1995). Who needs an MBA?. Physics World. 8(12). 15–18. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Pardo Breakdown of academic impact, for papers by Gianna Camiciottoli Breakdown of academic impact, for papers by Anna E. Sharrock Breakdown of academic impact, for papers by Charles Ruehle Breakdown of academic impact, for papers by Yuta Mori Breakdown of academic impact, for papers by Paul Tennant Breakdown of academic impact, for papers by Tony Lin Breakdown of academic impact, for papers by Hajime Kasai Breakdown of academic impact, for papers by Vičko Gluncić Breakdown of academic impact, for papers by Biljana Zvezdin
Rankless by CCL
2026